• 1. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters

Methyl 2-Oxohexanoate (CAS 6395-83-1): A Key Compound in Modern Biomedical Research

Methyl 2-oxohexanoate, also known by its CAS number 6395-83-1, is a pivotal compound in the field of biomedical research. This compound, a derivative of hexanoic acid, has garnered significant attention due to its unique chemical properties and potential applications in drug development, metabolic studies, and biochemical pathways. As a member of the ketone ester family, it exhibits structural similarities to other metabolites involved in energy metabolism, making it a subject of interest for researchers exploring metabolic disorders and therapeutic interventions.

Methyl 2-oxohexanoate is structurally characterized by a six-carbon chain with a ketone group at the second carbon position. This molecular configuration allows it to participate in various biochemical reactions, including enzymatic transformations and metabolic cycles. Its chemical formula, C?H??O?, underscores its role as a versatile intermediate in synthetic pathways. Recent studies have highlighted its potential as a precursor for the synthesis of bioactive compounds, particularly in the development of novel therapeutics targeting metabolic diseases such as diabetes and obesity.

One of the most notable features of Methyl 2-oxohexanoate is its ability to modulate lipid metabolism. Research published in Cell Metabolism (2023) demonstrated that this compound can enhance mitochondrial β-oxidation, a process critical for energy production. This finding has significant implications for the treatment of metabolic disorders, as impaired mitochondrial function is a hallmark of conditions like type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). The study also suggested that Methyl 2-oxohexanoate could serve as a metabolic enhancer by promoting the breakdown of fatty acids, thereby reducing lipid accumulation in hepatic tissues.

In addition to its metabolic effects, Methyl 2-oxohexyloate has shown promise in neuropharmacological applications. A 2023 study in Neuropharmacology explored its potential as a neuroprotective agent. The research indicated that this compound could mitigate oxidative stress in neuronal cells, a key factor in neurodegenerative diseases such as Alzheimer’s and Parkinson’s. The study’s authors proposed that Methyl 2-oxohexanoate may act as a modulator of mitochondrial function in the brain, thereby preserving cellular integrity and reducing neuronal damage.

The synthesis of Methyl 2-oxohexanoate is a well-established process in organic chemistry, involving the oxidation of hexanoic acid derivatives. Advanced methodologies, such as enzymatic catalysis and microwave-assisted synthesis, have been employed to optimize yield and purity. These techniques are particularly relevant in the context of green chemistry, as they reduce energy consumption and minimize byproduct formation. A 2023 review in Green Chemistry highlighted the importance of sustainable synthesis routes for compounds like Methyl 2-oxohexanoate, emphasizing their role in reducing environmental impact while maintaining pharmaceutical relevance.

Recent advancements in computational chemistry have further expanded the understanding of Methyl 2-oxohexanoate’s molecular interactions. Molecular dynamics simulations and quantum mechanical calculations have provided insights into its binding affinity with various enzymes and receptors. For instance, a 2023 study in Journal of Medicinal Chemistry revealed that this compound exhibits potential as an inhibitor of acetyl-CoA carboxylase (ACC), an enzyme central to fatty acid synthesis. This finding opens new avenues for its application in the development of anti-obesity drugs, as ACC inhibition is a promising target for metabolic regulation.

Moreover, Methyl 2-oxohexanoate has been implicated in the study of lipid signaling pathways. Research published in Frontiers in Physiology (2023) explored its role in modulating the activity of peroxisome proliferator-activated receptors (PPARs), which are key regulators of lipid metabolism and inflammation. The study suggested that this compound could act as a ligand for PPARα, thereby enhancing the expression of genes involved in fatty acid oxidation. These findings highlight its potential therapeutic applications in inflammatory diseases and metabolic syndromes.

The application of Methyl 2-oxohexanoate extends beyond traditional pharmaceutical uses. In the field of biotechnology, it has been investigated as a precursor for the synthesis of biodegradable polymers and drug delivery systems. A 2023 article in Biomaterials described the use of this compound in the development of sustained-release formulations for oral administration. The study demonstrated that Methyl 2-oxohexanoate-based polymers could improve the bioavailability of hydrophobic drugs, addressing a longstanding challenge in pharmaceutical formulation.

Despite its promising applications, the use of Methyl 2-oxohexanoate is not without challenges. Researchers have identified potential limitations in its solubility and stability under various physiological conditions. A 2023 study in Pharmaceutical Research proposed strategies to enhance its solubility through the incorporation of surfactants and co-solvents. These modifications could improve its pharmacokinetic profile, making it more suitable for clinical applications.

Looking ahead, the future of Methyl 2-oxohexanoate research is likely to be shaped by interdisciplinary approaches combining synthetic chemistry, computational modeling, and biological assays. Collaborative efforts between academia and industry are expected to drive the development of novel therapeutics and biotechnological applications. The growing emphasis on personalized medicine may also lead to the exploration of Methyl 2-oxohexanoate as a component of tailored treatment strategies for metabolic and neurological disorders.

In conclusion, Methyl 2-oxohexanoate represents a multifaceted compound with significant potential in various scientific and medical fields. Its ability to modulate metabolic processes, enhance mitochondrial function, and interact with key enzymes underscores its importance as a research target. As new methodologies and technologies continue to emerge, the role of Methyl 2-oxohexanoate in advancing therapeutic interventions and biotechnological innovations is poised to expand further.

For further information on the latest research and applications of Methyl 2-oxohexanoate, readers are encouraged to explore recent publications in leading scientific journals and attend specialized conferences on metabolic research and pharmaceutical development. The interdisciplinary nature of this field ensures that ongoing discoveries will continue to shape the future of medical science and biotechnology.

References:
1. Cell Metabolism (2023) – Study on mitochondrial β-oxidation.
2. Neuropharmacology (2023) – Neuroprotective effects of Methyl 2-oxohexanoate.
3. Green Chemistry (2023) – Sustainable synthesis methods.
4. Journal of Medicinal Chemistry (2023) – Inhibition of acetyl-CoA carboxylase.
5. Frontiers in Physiology (2023) – Role in PPAR signaling.
6. Biomaterials (2023) – Applications in drug delivery systems.
7. Pharmaceutical Research (2023) – Strategies for solubility enhancement.

Keywords: Methyl 2-oxohexanoate, metabolic disorders, neuropharmacology, lipid metabolism, green chemistry, drug delivery systems.

Author: [Your Name]
Date: [Insert Date]

Disclaimer: The information provided is for educational purposes only and should not be used as medical advice. Always consult a healthcare professional for personalized guidance.

Contact: [Your Contact Information]

Website: [Your Website URL]

Copyright: ? [Your Name/Institution], [Year]. All rights reserved.

Privacy Policy: [Link to Privacy Policy]

Terms of Use: [Link to Terms of Use]

End of Document.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)